Targeting cancer using KAT inhibitors to mimic lethal knockouts - Wikidata - awgldk - TriplyDB

Targeting cancer using KAT inhibitors to mimic lethal knockouts

Targeting cancer using KAT inhibitors to mimic lethal knockouts

http://www.wikidata.org/entity/Q26741346

about

Epigenetic modulators as therapeutic targets in prostate cancer Exploiting Epigenetic Alterations in Prostate Cancer.Circulating Nucleosomes and Nucleosome Modifications as Biomarkers in Cancer Epigenetic inactivation of tumour suppressor coding and non-coding genes in human cancer: an update.NDUFA4L2 is associated with clear cell renal cell carcinoma malignancy and is regulated by ELK1.In Vitro Histone Acetylation Assay.Epigenetic control of microsomal prostaglandin E synthase-1 by HDAC-mediated recruitment of p300.KAT3B-p300 and H3AcK18/H3AcK14 levels are prognostic markers for kidney ccRCC tumor aggressiveness and target of KAT inhibitor CPTH2.

P2860

Q28071912-5DD49D64-80DC-4DEB-8730-87B2CE9CF563 Q33755160-D64BB029-D29F-44FA-A2DE-5FF3C03D7941 Q37629542-FEFD0ABA-FE0E-4010-832D-A6A3CC690DF0 Q42281992-CEACACBC-1933-4ECB-A30B-693088822BEE Q47134100-57D11F80-F07C-40BF-BE95-0E6D6A8EB1C5 Q47271558-86724CD1-D594-4C2A-ADB1-88C8A42C1D44 Q49738731-F44DEB98-6949-4578-BAEB-E875C80F8C74 Q52597611-1446A829-D941-4472-AA9B-ECDE03FE4C7F

P2860

Targeting cancer using KAT inhibitors to mimic lethal knockouts

http://www.wikidata.org/entity/Q26741346

description

2016 nî lūn-bûn

@nan

2016 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Targeting cancer using KAT inhibitors to mimic lethal knockouts

@ast

Targeting cancer using KAT inhibitors to mimic lethal knockouts

@en

Targeting cancer using KAT inhibitors to mimic lethal knockouts

@nl

type

label

Targeting cancer using KAT inhibitors to mimic lethal knockouts

@ast

Targeting cancer using KAT inhibitors to mimic lethal knockouts

@en

Targeting cancer using KAT inhibitors to mimic lethal knockouts

@nl

prefLabel

Targeting cancer using KAT inhibitors to mimic lethal knockouts

@ast

Targeting cancer using KAT inhibitors to mimic lethal knockouts

@en

Targeting cancer using KAT inhibitors to mimic lethal knockouts

@nl

P1433

Q26741346-77129647-9FFC-45C7-81E1-240C067A290B

P1476

Q26741346-2E5A3932-06CE-4E67-B9B6-DD5C72B6CD76

P2093

Q26741346-31D06B7B-18C3-4158-98BD-2B34A05325EC

Q26741346-6C092563-0874-46EE-B980-0A5085381CDB

P275

Q26741346-E7E32306-92EC-499B-8568-41C0549C4787

P2860

Q26741346-011BFD3F-239C-4E2A-BF34-A61670CFDDA9

Q26741346-04D8D700-9E41-47A5-9579-48CB0DB2DCD3

Q26741346-05003807-F652-4AC1-9F31-75E284D0842E

Q26741346-0A087D38-E102-416E-9274-3BF125DDAFA1

Q26741346-0ADF551C-FF22-403A-92DA-F1281F349BFC

Q26741346-136BA0F2-8891-4418-AD9D-09ACAA0B76F6

Q26741346-143689C2-726B-434D-9D40-C973D54345C4

Q26741346-14412E3B-003B-441E-B690-613846AEA030

Q26741346-150837E8-74EA-40D4-BE79-D3F74CF2950D

Q26741346-16DAEC18-8CBF-43DE-A510-95DE9C0704CF

P304

Q26741346-A1B1A0F2-1E47-4C35-85A6-35DF4B12DC2F

P31

Q26741346-7B4CE2CB-E0D6-4360-B2A4-666081815A8F

P3181

Q26741346-BF517D50-234F-481F-842E-8DEB1841FAEB

P356

Q26741346-90537E89-6FA1-4BC0-AD67-F648F7C9B9A3

P407

Q26741346-EDAAD712-6FE3-4C7A-BBBA-1F15102DF501

P433

Q26741346-244CA55B-AAB6-4BA7-BC7D-4F0E892641D5

P478

Q26741346-7299DBB3-25A8-4978-A152-5B1E7650ECFA

P50

Q26741346-8E5D4DD2-A2FB-432B-9B46-13B421914689

Q26741346-AF8234B2-B973-4282-B6CB-5D88DC0B1640

P5008

Q26741346-93EE19BD-2EB6-4FE9-8D8D-842272EFA45B

P577

Q26741346-65536ECD-927F-433D-9BE4-2F62B18A2499

P698

Q26741346-4B5B6EFA-B77A-429E-B2AC-5AC3083EDDDF

P921

Q26741346-43B1263B-1A40-4B06-8935-3C6BC18CFB3A

Q26741346-8AB167EA-B7B1-4D4C-98F3-259721997770

Q26741346-FC86E22C-B2F6-488B-974B-45469C3EA8BB

P932

Q26741346-FF271F08-6CE6-4393-B073-0D504E87E34F

P3181

P356

P1433

Biochemical Society Transactions

P1476

Targeting cancer using KAT inhibitors to mimic lethal knockouts

@en

P2093

Leif A Eriksson

http://www.w3.org/2001/XMLSchema#string

Michael J Kerin

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International

P2860

MYST protein acetyltransferase activity requires active site lysine autoacetylation

Regulation of TIP60 by ATF2 modulates ATM activation

Perspectives on new synthetic curcumin analogs and their potential anticancer properties

KATs in cancer: functions and therapies

Acetylation of histone H4 by Esa1 is required for DNA double-strand break repair.

Computer-aided Molecular Design of Compounds Targeting Histone Modifying Enzymes

Cellular functions of TIP60

Activation of a Tip60/E2F1/ERCC1 network in human lung adenocarcinoma cells exposed to cisplatin

Role of Tip60 in human melanoma cell migration, metastasis, and patient survival

A role for the Tip60 histone acetyltransferase in the acetylation and activation of ATM

P304

979-986

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4373025

http://www.w3.org/2001/XMLSchema#string

P356

10.1042/BST20160081

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P50

P5008

P577

2016-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27528742

http://www.w3.org/2001/XMLSchema#string

P921

mechanism of action

P932

4984449

http://www.w3.org/2001/XMLSchema#string